Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
11.69
-0.13 (-1.10%)
Nov 20, 2025, 4:00 PM EST - Market closed
CRBP Market Cap
CRBP has a market cap or net worth of $205.2 million as of November 20, 2025. Its market cap has decreased by -6.94% in one year.
Market Cap
205.20M
Enterprise Value
103.26M
1-Year Change
-6.94%
Ranking
Category
Stock Price
$11.69
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $205.20M, an increase of 170.71%. That is a compound annual growth rate of 9.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 207.50M | 44.40% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
| Nov 11, 2014 | 75.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 244.75B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |